Navigation Links
Art Pappas Elected to NVCA Board of Directors
Date:5/15/2013

RESEARCH TRIANGLE PARK, N.C., May 15, 2013 /PRNewswire/ -- The National Venture Capital Association (NVCA) today announced the election of Arthur M. Pappas , managing partner of Pappas Ventures, to its board of directors. He will serve a four-year term. The appointment was made official at the association's annual meeting – VentureScape 2013 – in San Francisco.

Mr. Pappas has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies. He founded Pappas Ventures in 1994, and works with a team that has invested in numerous life science companies that have created novel innovative products addressing unmet medical needs. Prior to forming Pappas Ventures, he held senior level leadership positions at several multinational pharmaceutical companies, for which he led operations and was responsible for the development, licensing and launch of a number of global products.

The NVCA serves as the venture capital community's trade association, representing more than 400 members by advocating for policies that encourage innovation and reward long term investment.

"It is an honor and a pleasure to join the NVCA Board of Directors, especially during such a critical time for the venture capital industry," said Mr. Pappas. "I look forward to working with the organization and the board in developing policies that can further foster innovation and facilitate the creation of good jobs throughout the U.S. economy."

The NVCA also appointed Josh Green , general partner of Mohr Davidow Ventures to serve as the 2013-2014 Chairman of the Board of Directors, effective immediately. Mr. Pappas joins the board along with five other newly-elected directors; Scott Kupor , Andreessen Horowitz; Sue Siegel <
'/>"/>

SOURCE Pappas Ventures
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SoundConnect Recently Selected by iCIMS, Inc.
2. Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
3. ExakTime’s GeoTrakker Selected for 2013 Most Innovative Product Award Program
4. Greenphires ClinCard Technology Platform selected by Bavarian Nordic for Major Vaccine Trial
5. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
6. American Physical Society elected physicist Markus Aspelmeyer as a Fellow
7. Topricin Selected for Bruce Springsteen MusiCares’ Tribute Gala
8. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
9. INRS: Professor Federico Rosei elected AAAS Fellow in recognition of his meritorious efforts to advance science
10. Cantrell Selected to Lead Kansas Bioscience Authority
11. Companies Selected to Present at AdvaMed 2012 Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... 23, 2014 Earlier this year in a ... of the Adult Stem Cell Technology Center, LLC ( ASCTC ... unique property of adult tissue stem cells. His title ... Important for the Future,” embodied the essence of his message ...
(Date:12/24/2014)... December 23, 2014 The report ... its definition, classification, application and industry overview. This ... product cost structure. Production is separated by regions, ... raw materials, equipment, downstream client survey, marketing channels, ...
Breaking Biology Technology:Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: NBS ) ("NeoStem" or the "Company"), an ... Company,s Chief Executive Officer, Robin Smith , M.D., will,ring the opening bell at ... a.m. ET on Thursday, May 27, 2010 . , ... "We are honored to be back at the ...
... BEIJING , May 26 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ... that the Company,will participate at the 2010 Shanghai CPhI Exhibition, being held ... E4, No. E4C42. At the,exhibition, Sinovac will showcase its commercialized products, including ... , , ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ... Research Center at the University of Texas ... has started patient enrolment in a U.S. Phase 2 ... with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. ...
Cached Biology Technology:NeoStem to Ring Opening Bell at New York Stock Exchange on May 27, 2010 2NeoStem to Ring Opening Bell at New York Stock Exchange on May 27, 2010 3NeoStem to Ring Opening Bell at New York Stock Exchange on May 27, 2010 4Sinovac to Participate at 2010 Shanghai CPhI Exhibition 2Sinovac to Participate at 2010 Shanghai CPhI Exhibition 3Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial 2Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial 3Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial 4
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season may be ... Market Intelligence reports that the long anticipated floodgates for ... intensifying demand for smart phones, tablets, and wearable mobile ... of 2.5 billion users with nearly 4.8 billion biometric ...
(Date:12/19/2014)... Inc., the leading personal genetics company, today announced the publication ... of individuals from across the United States ... hundred years ago, the United States ... continents. This study illuminates how American history and the ongoing ...
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 The ... it easier to detect and prevent counterfeit microcircuits from ... agency started performing an in-house microcircuit anti-counterfeit initiative dubbed ... purchased microcircuits while increasing their reliability throughout the supply ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... This press release is available in French . ... lot safer for consumers, thanks to Concordia University researchers who,ve ... dairy and other products. "Even though Canada does not ... cows, until now there were no methods or equipment to ...
... nature of one of the simplest chemical compounds -- the ... -- add another odd twist. Scientists are reporting that good ... into a new type of liquid. The report appears in ... Kumar and H. Eugene Stanley explain that water is one ...
... plants are capable of complex social behaviours and may ... strangers. A growing body of work ... identity of their neighbours. But can plants cooperate with ... perform best -- suggesting altruism towards relatives -- other ...
Cached Biology News:Do plants perform best with family or strangers? Researchers consider social interactions 2
... introduced QPatch HT is taking automated patch clamping ... With its ability to generate thousands of high ... new screening paradigms in ion channel drug discovery ... same high quality afforded by conventional patch clamping ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. These microarrays are available ... Microarray Service. Probe Content ... greater than 1500 known aptamer sequences. Add ...
... provides a comprehensive service for custom ... peptide microarrays synthesized on Paraflo microfluidic ... proteins/antibodies or serum samples. This comprehensive ... designs, binding assays using sample(s) provided ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. Thousands of customer specified ... Sciences can provide assistance with custom sequence ... of our comprehensive DNA/RNA Aptamer Microarray Service. ...
Biology Products: